Who Supplies Collagen to India from SINGAPORE

To import finished pharmaceutical formulations containing collagen into India, the foreign manufacturer must obtain an Import Registration Certificate and an Import License from the Central Drugs Standard Control Organization (CDSCO). The registration process involves submitting an application to the Drugs Controller General of India (DCGI), along with necessary documents such as the Free Sale Certificate, Good Manufacturing Practice (GMP) certificate, and manufacturing license. The registration certificate is valid for three years from the date of issue. The import license is also valid for three years and is required for each consignment. The application process typically takes several months, depending on the completeness of the submitted documents and the inspection schedule. For formulations under HS Code 30049099, specific requirements include stability data (preferably ICH Zone IV), and compliance with the Indian Pharmacopoeia standards.

Imported finished pharmaceutical formulations containing collagen must undergo quality testing at CDSCO-approved laboratories in India. Each batch requires a Certificate of Analysis (CoA) confirming compliance with Indian Pharmacopoeia standards. Stability data, preferably from ICH Zone IV studies, must be provided to demonstrate the product's shelf-life under Indian climatic conditions. Port inspection by customs drug inspectors is mandatory to verify the authenticity and quality of the imported products. The testing process can take several weeks, and if a batch fails to meet the required standards, it may be rejected or require reprocessing.

In April 2025, the CDSCO introduced new regulations mandating import registration and licenses for all imported drugs, including finished formulations containing collagen. This measure aims to prevent the sale of unapproved or illegal medicines in the Indian market. The regulations also stipulate that drugs manufactured in Special Economic Zones (SEZs) for export purposes are not permitted for transfer to the Domestic Tariff Area (DTA) for sale and distribution. These changes are part of India's ongoing efforts to streamline drug import procedures and ensure the quality, safety, and efficacy of pharmaceutical products available domestically.

India imports finished collagen formulations to meet the demand for specialized dosage forms and patented or branded products not manufactured domestically. The domestic capacity for producing collagen-based formulations is limited, leading to a reliance on imports to fulfill market needs. The market size for collagen formulations in India is growing, driven by increasing awareness of their therapeutic benefits and applications in various medical fields.

The Basic Customs Duty (BCD) for finished pharmaceutical formulations under HS Code 30049099 is 10%. An additional Social Welfare Surcharge (SWS) of 10% on the BCD is applicable. The Integrated Goods and Services Tax (IGST) is 12%. Considering these components, the total landed duty for importing such formulations into India is approximately 23.536%.

Singapore is a preferred source for importing finished collagen formulations into India due to its advanced manufacturing capabilities, adherence to international quality standards, and the availability of specialized dosage forms. Singapore's pharmaceutical industry is known for its innovation and compliance with Good Manufacturing Practices (GMP), making it a reliable supplier. Other potential suppliers include China, Germany, and the United States; however, Singapore's strategic location, robust regulatory framework, and established trade relations with India provide it with a competitive advantage in this market segment.

India imports collagen formulations from Singapore due to the latter's advanced manufacturing capabilities, adherence to international quality standards, and the availability of specialized dosage forms not produced domestically. Singapore's pharmaceutical industry is known for its innovation and compliance with Good Manufacturing Practices (GMP), making it a reliable supplier for India's growing demand for collagen-based products.

Compared to other potential suppliers like China, Germany, and the United States, Singapore offers a competitive advantage in terms of quality, regulatory compliance, and reliability. While China may offer lower prices, concerns about quality and regulatory standards can be a drawback. Germany and the United States provide high-quality products but may have higher costs and longer lead times. Singapore's strategic location, robust regulatory framework, and established trade relations with India make it a preferred source for collagen formulations.

Indian importers face several supply chain risks when sourcing collagen formulations from Singapore, including single-source dependency, currency fluctuations, regulatory changes, quality incidents, and shipping disruptions. To mitigate these risks, importers should consider diversifying their supplier base, closely monitoring currency exchange rates, staying updated on regulatory changes, implementing stringent quality control measures, and maintaining buffer stocks to manage potential shipping delays.

1. 1Dual-Sourcing: Engage multiple suppliers to reduce dependency on a single source and mitigate supply chain risks.
2. 2Inventory Planning: Maintain optimal inventory levels to buffer against potential shipping delays or supply disruptions.
3. 3Payment Terms: Negotiate favorable payment terms, such as Letters of Credit (LC), Documents Against Payment (DA), or Documents Against Acceptance (DP), to manage financial risks.
4. 4Supplier Qualification: Conduct thorough due diligence on potential suppliers, including audits of manufacturing facilities and reviews of quality certifications.
5. 5Regulatory Compliance: Ensure that all imported formulations comply with Indian regulatory requirements, including CDSCO registration and quality testing.

Implementing these strategies can enhance the reliability and efficiency of the procurement process for collagen formulations from Singapore.

1. DGFT Importer Exporter Code (IEC): Obtain an IEC from the Directorate General of Foreign Trade.